Prasinezumab

Tax included
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research.
MedChemExpress 
HY-P99405

Data sheet

Size
Multiple sizes
Reactivity
α-synuclein
Application
Neuroscience-Neurodegeneration
CAS
1960462-19-4